GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinopep Allsino Bio Pharmaceutical Co Ltd (SHSE:688076) » Definitions » Net Income Including Noncontrolling Interests

Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Net Income Including Noncontrolling Interests : ¥165 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Sinopep Allsino Bio Pharmaceutical Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Sinopep Allsino Bio Pharmaceutical Co's Net Income Including Noncontrolling Interests for the three months ended in Dec. 2023 was ¥75 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 was ¥165 Mil.

Sinopep Allsino Bio Pharmaceutical Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Sinopep Allsino Bio Pharmaceutical Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopep Allsino Bio Pharmaceutical Co Net Income Including Noncontrolling Interests Chart

Sinopep Allsino Bio Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.81 120.03 108.81 122.77 165.45

Sinopep Allsino Bio Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.12 18.89 20.97 50.49 75.11

Sinopep Allsino Bio Pharmaceutical Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥165 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinopep Allsino Bio Pharmaceutical Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Sinopep Allsino Bio Pharmaceutical Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinopep Allsino Bio Pharmaceutical Co Ltd (SHSE:688076) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
SHSE:600201 SHSE:688062 SZSE:000990 SHSE:605116 SHSE:688382 SZSE:300049 SHSE:600645 SZSE:301047 SZSE:300255 SZSE:300841 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 28, Linpu Road, Economic and Technological Development Zone, Jiangsu Province, Lianyungang, CHN, 222069
Website
http://www.sinopep.com.cn
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.

Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Headlines

No Headlines